On-line Supplementary Material for Journal of Solution Chemistry Studies of Size-Based Selectivity in Aqueous Ternary Complexes of Americium(III) or Lanthanide(III) Cations Christina J. Leggett · Mark P. Jensen C.J. Leggett · M.P. Jensen () Chemical Sciences and Engineering Division, Argonne National Laboratory, Argonne, IL, USA e-mail: mjensen@anl.gov C.J. Leggett Department of Nuclear Engineering, University of California, Berkeley, CA, USA S1 Analysis of Tb Spectrofluorimetric Data Two approaches were used to analyze the spectrofluorimetric titrations of Tb(CDTA)– with Ox2–. In the first method, the change in the luminescence lifetime of the Tb species in solution was used. The average number of inner sphere water molecules of a Eu3+ or Tb3+ complex, 𝑁Hobs , is 2O related to the luminescence decay constants by Nobs H2 O = (kH2 O – kD2 O )ALn (S1) where 𝑘H2 O and 𝑘D2 O are the luminescence decay constants of the complexes in H2O and D2O, respectively, in ms–1 and ALn is an empirically determined constant. The values of 𝑘D2O (0.30) and ATb (4.2) have been previously reported by Horrocks and Sudnick, who also report the absolute uncertainty in 𝑁Hobs determined by this method to be 0.5 water molecules [1]. 2O Consequently, we used the number of inner sphere water molecules bound to Tb(CDTA)– and Tb(CDTA)(Ox)3– as a function of added oxalate concentration to calculate the equilibrium constant. When Tb(CDTA)– and Tb(CDTA)(Ox)3– are the only significant Tb(III) containing species in solution, the average number of water molecules can be calculated using the equation Nobs H2 O = NTb(CDTA) NTb(CDTA)(Ox) [Tb(CDTA)– ] [Tb(CDTA)(Ox)3- ] CTb tot CTb tot + (S2) where NTb(CDTA) and NTb(CDTA)(Ox) are the numbers of waters coordinated to Tb(CDTA)– and Tb Tb(CDTA)(Ox)3–, respectively, and Ctot is the total concentration of terbium in a given solution. Using equation S1 and the measured 𝑘H2 O , 0.79 ms–1, the number of residual water molecules bound to the binary Tb(CDTA)– complex, NTb(CDTA), was readily determined to be 2.07, as expected for octacoordinate terbium complexed by hexadentate CDTA. Introducing the equilibrium constant expression for K111 (Eq. 1) and realizing that [Tb(CDTA)–] + Tb [Tb(CDTA)(Ox)3–] = CTot , NTbCDTAOx and K111 can be obtained from Eq. S2. The solver function in Excel was used to minimize the sum of the squared residuals between the observed and calculated number of water molecules by varying NTbCDTAOx and K111. For each titration, eighteen data points corresponding to successive additions of 0.075 mol·L–1 oxalate were collected and used for fitting, giving NTbCDTAOx = 0.51 0.01 and log10 K111 = 2.78 0.02. In the second method, the intensity of emitted fluorescence at 544 nm was used to calculate the equilibrium constant according to the equation – Icalc n = ε1 [Tb(CDTA) ] + ε2 [Tb(CDTA)(Ox)3– ] (S3) where Incalc is the measured fluorescence intensity and the constants 1 and 2 are the operational molar fluorescence intensities of Tb(CDTA)– and Tb(CDTA)(Ox)3–, which are valid for a particular instrumental configuration. The value of 1, (2.48 0.03) × 103 L·mol–1·cm–1, was determined from intensity measurements of known concentrations of Tb(CDTA)–. The terms 2 and K111 were then obtained by fitting to the experimental titration data in a manner similar to the luminescence lifetime measurements described above, giving values of 2 = (4.24 0.08) × 103 L·mol–1·cm–1 and log10 K111 = 2.75 0.02. The uncertainties in the fitted parameters for both methods were estimated using the jackknife error method. [2] S2 Determination of the Enthalpies of Protonation of CDTA The enthalpies corresponding to the first three protonations of the CDTA4– ligand were measured at 1 mol·L–1 ionic strength using isothermal titration calorimetry. In a typical experiment, 0.9 mL of 0.001 mol·L–1 CDTA/1 mol·L–1 NaNO3 at pcH = 9.9 was titrated with 0.1 mL of 0.031 mol·L–1 HNO3/1 mol·L–1 NaNO3 in 2 μL increments. Using the known pKa values [3], the pcH and changes in the amounts of H(CDTA)3–, H2(CDTA)2–, and H3(CDTA)– were readily calculated for each addition of acid. The total heat evolved from the beginning of the titration was calculated using the equation ∑(∆Hi ∆ni ) = –Qcalc (S4) i where ΔHi is the enthalpy of protonation for HiCDTA(i–4) in kJ·mol–1, Δni is the change in the number of moles of HiCDTA(i–4) from the beginning of the titration, and Qcalc is the cumulative heat after each addition, after correction for the heat of dilution and the heat of water formation by the reaction H+ + OH– ® ¬ H2O. The Solver application in the program Excel was used to minimize the sum of the squared residuals between the calculated and measured cumulative heats by varying ΔHi. Four replicate titrations were used to determine the enthalpies. Figure S1 compares the calculated and measured heats from a representative titration. Table S1 Thermodynamic data for protonation reactions of ligands used in this work Ligand Protonation reaction(s) log10 K a H(prot), kJ·mol–1 b ® ¬ 9.98 0.08 –33 0.4 c 8.29 0.04 –18 0.4 c H+ + DTPA5– ® ¬ H+ + HDTPA4– H5DTPA HDTPA4– H+ + H2DTPA3– ® ¬ H3DTPA2– 4.15 0.03 –6.3 0.4 c H+ + H3DTPA2– ® ¬ H4DTPA– 2.6 0.1 –1.3 0.8 c 2.1 0.2 +2.1 0.8 c HOx– 3.57 0.04 +3.2 0.3 H2Ox 1.07 0.07 +1.3 HMal– 5.08 0.06 +2.0 0.04 H2Mal 2.58 0.02 –1.5 0.04 HIDA– 9.26 0.06 –35.6 0.0 H2IDA 2.60 0.03 –4.2 0.8 H3IDA+ 1.85 0.06 –4.2 0.0 9.22 –25.6 0.3 d H2CDTA2– 5.84 –12.4 0.4 d H3CDTA– 3.21 0.04 –8.6 2.4 d 2.42 0.01 n/a 1.6 0.1 n/a 6.194 0.008 e –4.35 0.07 e ® ¬ H+ + H4DTPA– H2Mal H+ + CDTA4– ® ¬ ® ¬ ® ¬ ® ¬ HCDTA3– ® ¬ H+ + HCDTA3– ® ¬ H+ + H2CDTA2– H+ + H3CDTA– H+ + H4CDTA HMES ¬ ® H+ + HIDA– H+ + H2IDA H4CDTA ® ¬ H+ + HMal– H+ + IDA2– H2IDA ® ¬ H+ + HOx– H+ + Mal2– H+ + MES H5DTPA ® ¬ H+ + Ox2– H2Ox H2DTPA3– ® ¬ ® ¬ ® ¬ H4CDTA H5CDTA+ HMES OH– H+ + OH– ® ¬ H2O 13.78 –56.94 All stability constants are valid for 1 mol·L–1 ionic strength at 25 °C. Unless otherwise noted, data are taken from [3] b Unless otherwise noted, all enthalpy values are valid for 1 mol·L–1 ionic strength at 25 °C and were obtained from [3] c Enthalpy values valid for ionic strength = 0.1 mol·L–1 at 25 °C d Enthalpy values measured in present work. e Values taken from [4] a Table S2 Tabulation of calorimetric titration data for titration of Ln(CDTA)– with Ox2– – Ln(CDTA) [Ln(CDTA)–] / Runs [Ox] / a –1 b mol·L –1 b pcHfinal Qmeas / cal Qdil / cal Qprot / cal Qcorr / cal mol·L Nd(CDTA)– 4 0.0100 0.0733 6.003 0.188 ± 0.004 –0.017 ± 0.018 0.003 ± 0.001 0.202 ± 0.018 Sm(CDTA)– 3 0.0100 0.0733 6.034 0.178 ± 0.001 –0.017 ± 0.018 0.001 ± 0.001 0.194 ± 0.018 Tb(CDTA)– 4 0.0100 0.0753 6.003 0.294 ± 0.008 –0.017 ± 0.018 0.002 ± 0.002 0.312 ± 0.020 Ho(CDTA)– 4 0.0101 0.0733 5.991 0.262 ± 0.008 –0.017 ± 0.018 0.001 ± 0.001 0.278 ± 0.020 Er(CDTA)– 4 0.0100 0.0733 5.991 0.312 ± 0.008 –0.017 ± 0.018 0.001 ± 0.001 0.328 ± 0.020 a b Number of replicate titrations Initial analytical concentrations of titrant and titrand solutions used in titrations Table S3 Tabulation of calorimetric titration data for titration of Ln(CDTA)– with Mal2– – Ln(CDTA) [Ln(CDTA)–] / Runs [Mal] / a –1 b mol·L –1 b pcHfinal Qmeas / cal Qdil / cal Qprot / cal Qcorr / cal mol·L Nd(CDTA)– 5 0.0402 0.502 5.965 0.035 ± 0.004 –0.107 ± 0.008 0.062 ± 0.001 0.080 ± 0.009 Sm(CDTA)– 3 0.0401 0.502 5.958 –0.125 ± 0.016 –0.107 ± 0.008 0.062 ± 0.001 –0.080 ± 0.018 Ho(CDTA)– 3 0.00395 1.022 5.995 –0.569 ± 0.006 –0.472 ± 0.018 0.029 ± 0.001 –0.126 ± 0.019 Er(CDTA)– 4 0.0394 1.022 5.990 –0.475 ± 0.009 –0.472 ± 0.018 0.029 ± 0.001 –0.032 ± 0.020 a b Number of replicate titrations Initial analytical concentrations of titrant and titrand solutions used in titrations Table S4 Tabulation of calorimetric titration data for titration of Ln(CDTA)– with IDA2– – Ln(CDTA) [Ln(CDTA)–] / Runs [IDA] / a –1 b mol·L –1 b pcHfinal Qmeas / cal Qdil / cal Qprot / cal Qcorr / cal mol·L Nd(CDTA)– 3 0.0103 1.499 6.716 –1.137 ± 0.020 –0.949 ± 0.010 –0.464 ± 0.002 0.276 ± 0.022 Sm(CDTA)– 4 0.0216 1.499 6.392 –0.886 ± 0.012 –0.949 ± 0.010 –1.010 ± 0.010 1.073 ± 0.016 Ho(CDTA)– 3 0.0101 1.499 6.742 –0.794 ± 0.003 –0.949 ± 0.010 –0.391 ± 0.002 0.546 ± 0.011 Er(CDTA)– 3 0.00999 1.499 6.802 –0.756 ± 0.003 –0.949 ± 0.010 –0.300 ± 0.002 0.493 ± 0.011 a b Number of replicate titrations Initial analytical concentrations of titrant and titrand solutions used in titrations Figure S1 Representative titration of 0.9 mL of 0.001 mol·L–1 CDTA/1 mol·L–1 NaNO3 (initial pcH = 9.9) with 0.1 mL of 0.031 mol·L–1 HNO3/1 mol·L–1 NaNO3. The blue diamonds represent the cumulative heat after each 0.002 mL addition of titrant. The solid line shows the fit of the calculated heats obtained by varying ΔHi to minimize the sum of the squared residuals Figure S2 Normalized Sm(CDTA)– + Ox2– spectra. Left plot, titration of 10 mL of 0.01 mol·L–1 Sm(CDTA)– with 0.075 mol·L–1 oxalate; right plot, molar absorptivities at selected wavelengths as a function of the total oxalate concentration. Wavelengths shown are indicated as follows: , 403.75 nm; , 404.1 nm; , 404.45 nm Figure S3 Normalized Sm(CDTA)– + Mal2– spectra. Left plot, titration of 10 mL of 0.01 mol·L–1 Sm(CDTA)– with 0.50 mol·L–1 malonate; right plot, molar absorptivities at selected wavelengths as a function of the total malonate concentration. Spectra are not corrected for absorption of the free Mal2– ligand. Wavelengths shown are indicated as follows: , 403.75 nm; , 404.25 nm; , 405 nm Figure S4 Normalized Sm(CDTA)– + IDA2– spectra. Left plot, titration of 10 mL of 0.022 mol·L–1 Sm(CDTA)– with 1.50 mol·L–1 IDA; right plot, molar absorptivities at selected wavelengths as a function of the total IDA concentration. Wavelengths shown are indicated as follows: , 404.9 nm; , 405.2 nm; , 405.5 nm Figure S5 Normalized Ho(CDTA)– + Ox2– spectra. Left plot, titration of 10 mL of 0.01 mol·L–1 Ho(CDTA)– with 0.073 mol·L–1 oxalate; right plot, molar absorptivities at selected wavelengths as a function of the total oxalate concentration. Wavelengths shown are indicated as follows: , 451.5 nm; , 453.5 nm; , 454.5 nm; *, 538 nm Figure S6 Normalized Ho(CDTA)– + Mal2– spectra. Left plot, titration of 10 mL of 0.01 mol·L–1 Ho(CDTA)– with 1.02 mol·L–1 malonate; right plot, molar absorptivities at selected wavelengths as a function of the total malonate concentration. Wavelengths shown are indicated as follows: , 451.5 nm; , 453.5 nm; , 454.5 nm Figure S7 Normalized Ho(CDTA)– + IDA2– spectra. Left plot, titration of 25 mL of 0.01 mol·L–1 Ho(CDTA)– with 1.50 mol·L–1 IDA; right plot, molar absorptivities at selected wavelengths as a function of the total IDA concentration. Wavelengths shown are indicated as follows: , 453.5 nm; , 454.5 nm; *, 539.75 nm Figure S8 Normalized Er(CDTA)– + Ox2– spectra. Left plot, titration of 10 mL of 0.01 mol·L–1 Er(CDTA)– with 0.073 mol·L–1 oxalate; right plot, molar absorptivities at selected wavelengths as a function of the total oxalate concentration. Wavelengths shown are indicated as follows: , 379.25 nm; , 518.75 nm; , 521 nm; , 525.25 nm Figure S9 Normalized Er(CDTA)– + Mal2– spectra. Left plot, titration of 10 mL of 0.01 mol·L–1 Er(CDTA)– with 0.50 mol·L–1 malonate; right plot, molar absorptivities at selected wavelengths as a function of the total malonate concentration. Wavelengths shown are indicated as follows: *, 487 nm; , 518 nm; , 520.75 nm; , 525 nm Figure S10 Normalized Er(CDTA)– + IDA2– spectra. Left plot, Titration of 10 mL of 0.01 mol·L–1 Er(CDTA)– with 1.50 mol·L–1 IDA; right plot, molar absorptivities at selected wavelengths as a function of the total IDA concentration. Wavelengths shown are indicated as follows: , 379.2 nm; , 520 nm; , 522.4 nm; , 525.6 nm Figure S11 Spectra of M(DTPA) and M(DTPA) + L2 solutions. Top plot, Nd(III) complexes; bottom plot, Er(III) complexes References 1. Horrocks Jr., W.D., Sudnick, D.R.: Lanthanide ion luminescence probes of the structure of biological macromolecules. Acc. Chem. Res. 14, 384–392 (1981) 2. Caceci, M. S.: Estimating error limits in parametric curve fitting. Anal. Chem. 61, 2324–2327 (1989) 3. Smith, R., Martell, A., Motekaitis, R.: NIST Critically Selected Stability Constants of Metal Complexes Database Vol. 8. NIST, Gaithersburg, MD (2004) 4. Leggett, C. J., Liu, G., Jensen, M. P.: Do aqueous ternary complexes influence the TALSPEAK Process? Solvent Extr. Ion Exch. 28, 313–334 (2010)